Analysts: Acura Pharmaceuticals Inc (ACUR.O)

ACUR.O on Consolidated Issue listed on NASDAQ Capital Market

0.98USD
29 Aug 2014
Price Change (% chg)

$0.00 (+0.12%)
Prev Close
$0.98
Open
$0.98
Day's High
$0.99
Day's Low
$0.96
Volume
64,991
Avg. Vol
97,159
52-wk High
$2.23
52-wk Low
$0.81

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.08 December 29 Aug 2014

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 1 1 1 2
(3) HOLD 1 1 1 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.50 2.50 2.50 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-14 2 0.10 0.10 0.10 --
Quarter Ending Dec-14 2 7.60 15.10 0.10 --
Year Ending Dec-14 2 7.75 15.20 0.30 16.43
Year Ending Dec-15 2 1.55 2.40 0.70 12.71
Earnings (per share)
Quarter Ending Sep-14 2 -0.08 -0.07 -0.08 --
Quarter Ending Dec-14 2 0.07 0.22 -0.08 --
Year Ending Dec-14 2 -0.16 0.00 -0.31 0.02
Year Ending Dec-15 2 -0.28 -0.27 -0.29 0.07

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-14 0.07 0.04 0.04 51.72
Quarter Ending Mar-14 0.40 0.04 0.36 89.50
Quarter Ending Dec-13 0.22 0.04 0.18 83.72
Quarter Ending Sep-13 0.06 0.08 0.02 27.69
Quarter Ending Jun-13 0.07 0.00 0.07 98.51
Earnings (per share)
Quarter Ending Jun-14 -0.08 -0.07 0.01 -12.50
Quarter Ending Mar-14 -0.05 -0.08 0.03 -60.00
Quarter Ending Dec-13 -0.06 -0.07 0.01 -16.67
Quarter Ending Sep-13 -0.07 -0.07 0.00 -0.00
Quarter Ending Jun-13 -0.08 -0.07 0.01 -12.50

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-14 0.10 0.08 0.08 0.08 --
Quarter Ending Dec-14 7.60 7.58 7.58 7.58 --
Year Ending Dec-14 7.75 7.75 7.75 7.75 16.43
Year Ending Dec-15 1.55 1.56 1.56 1.56 12.71
Earnings (per share)
Quarter Ending Sep-14 -0.08 -0.08 -0.08 -0.08 --
Quarter Ending Dec-14 0.07 0.07 0.08 0.08 --
Year Ending Dec-14 -0.16 -0.16 -0.16 -0.16 0.02
Year Ending Dec-15 -0.28 -0.28 -0.28 -0.28 0.07

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-14 1 0 1 0
Quarter Ending Dec-14 1 0 1 0
Year Ending Dec-14 0 0 0 0
Year Ending Dec-15 0 1 0 1
Earnings
Quarter Ending Sep-14 0 0 0 0
Quarter Ending Dec-14 0 0 0 1
Year Ending Dec-14 0 0 0 0
Year Ending Dec-15 0 0 1 0

Analyst Research Reports

Report Title Price
Provider: S&P Capital IQ Quantitative Report
$127.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks